Table 4.
Parameter | Group C | Group NC | p |
---|---|---|---|
SPPB | |||
Score values, M, SD | 6.00 ± 2.01 | 6.27 ± 2.05 | 0.414 * |
Low performance, values 0–6, N (%) | 50 (58.14) | 49 (69.01) | 0.919 ** |
Intermediate performance, values 7–9, N (%) | 36 (41.86) | 22 (30.99) | 0.066 ** |
High performance, values 10–12, N (%) | 0 (0) | 0 (0) | - |
Balance, M, SD | 1.58 ± 0.61 | 1.75 ± 0.53 | 0.063 * |
4-m walk, M, SD | 2.02 ± 0.92 | 1.99 ± 0.92 | 0.798 * |
Chair standing, M, SD | 2.43 ± 1.44 | 2.54 ± 1.45 | 0.648 * |
SARC-F | |||
Score values, M, SD | 5.04 ± 2.17 | 4.24 ± 2.43 | 0.035 * |
Sarcopenie, values ≥ 4, N (%) | 32 (37.21) | 23 (32.39) | 0.224 ** |
Strength, M, SD | 1.25 ± 0.67 | 0.92 ± 0.63 | 0.002 * |
Assistance walking, M, SD | 0.71 ± 0.63 | 0.68 ± 0.65 | 0.773 * |
Rise from a chair, M, SD | 1.26 ± 0.56 | 1.04 ± 0.46 | 0.009 * |
Climb stairs, M, SD | 1.32 ± 0.52 | 1.14 ± 0.49 | 0.030 * |
Falls, M, SD | 0.52 ± 0.65 | 0.46 ± 0.67 | 0.620 * |
SPPB, short physical performance battery; SARC-F, strength, ambulation, rising from a chair, stair climbing and history of falling; C, COVID-19 patients; NC, non-COVID-19; M patients, mean value; SD, standard deviation value; N, total number; p values, statistical significance (*, t-test, **, chi-square test).